Conception and design: Uwe Platzbecker, Xiaosha Zhang, Kenneth M. Attie
Provision of study materials or patients: Uwe Platzbecker, Katharina S. Götze, Philipp Kiewe, Ulrich Germing, Karin Mayer, Markus Radsak, Thomas Wolff, Joerg Chromik, Katja Sockel, Thomas Illmer, Haifa Kathrin Al‐Ali, Gerda Silling, Aristoteles Giagounidis
Collection and assembly of data: Uwe Platzbecker, Katharina S. Götze, Philipp Kiewe, Ulrich Germing, Karin Mayer, Markus Radsak, Thomas Wolff, Joerg Chromik, Katja Sockel, Uta Oelschlägel, Detlef Haase, Thomas Illmer, Haifa Kathrin Al-Ali, Gerda Silling, Aristoteles Giagounidis
Data analysis and interpretation: All authors
Manuscript writing: All authors
Final approval of manuscript: All authors
Accountable for all aspects of the work: All authors
AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).
Uwe Platzbecker
Honoraria: Celgene/Jazz, AbbVie, Curis, Geron, Janssen
Consulting or Advisory Role: Celgene/Jazz, Novartis, BMS GmbH & Co KG
Research Funding: Amgen (Inst), Janssen (Inst), Novartis (Inst), BerGenBio (Inst), Celgene (Inst), Chris (Inst)
Patents, Royalties, Other Intellectual Property: Part of a patent for a TFR-2 antibody
Travel, Accommodations, Expenses: Celgene
Katharina S. Götze
Honoraria: BMS
Consulting or Advisory Role: Celgene/BMS, AbbVie, Servier/Pfizer
Research Funding: BMS
Philipp Kiewe
Consulting or Advisory Role: Roche, Bristol Myers Squibb/Celgene, BeiGene, Amgen, Pfizer, AstraZeneca/Merck
Speakers’ Bureau: Excellence in Oncology
Ulrich Germing
Honoraria: Celgene/BMS, Jazz Pharmaceuticals, Novartis
Consulting or Advisory Role: Celgene
Research Funding: Celgene (Inst), Novartis (Inst)
Karin Mayer
Stock and Other Ownership Interests: Roche Pharma AG, Autolus Therapeutics, Merck Serono, Pfizer, Gilead Sciences, BMSi
Markus Radsak
Honoraria: Celgene
Consulting or Advisory Role: Takeda, Novartis, CORAT
Thomas Wolff
Honoraria: AstraZeneca, Apogepha, AbbVie, Incyte, Seagan
Consulting or Advisory Role: Roche
Katja Sockel
Honoraria: Bristol Myers Squibb/Celgene, Novartis, Alexion Pharmaceuticals, SOBI
Consulting or Advisory Role: Takeda, Novartis
Travel, Accommodations, Expenses: Jazz Pharmaceuticals, Celgene/Bristol Myers Squibb
Detlef Haase
Honoraria: Novartis, Jazz Pharmaceuticals, Takeda, Celgene/Bristol Myers Squibb
Research Funding: Celgene/BMSD
Travel, Accommodations, Expenses: Celgene/Bristol Myers Squibb
Thomas Illmer
Consulting or Advisory Role: Novartis, AstraZeneca, AbbVie
Haifa Kathrin Al-Ali
Honoraria: Novartis, BMSi, Incyte (Inst), Takeda, Pfizer, AbbVie
Consulting or Advisory Role: Novartis, BMSi, AbbVie
Research Funding: Novartis (Inst), BMSi (Inst), Incyte (Inst)
Travel, Accommodations, Expenses: BMSi, Novartis
Gerda Silling
Travel, Accommodations, Expenses: AbbVie
Joseph G. Reynolds
Employment: Acceleron Pharma, Inc, C4 Therapeutics
Stock and Other Ownership Interests: Acceleron Pharma, Inc
Xiaosha Zhang
Employment: Acceleron Pharma, Inc
Stock and Other Ownership Interests: Acceleron Pharma, Inc
Kenneth M. Attie
Employment: Acceleron Pharma, Inc, Imara
Leadership: Imara
Jeevan K. Shetty
Employment: Bristol Myers Squibb/Celgene
Stock and Other Ownership Interests: Bristol Myers Squibb/Celgene
Aristoteles Giagounidis
Stock and Other Ownership Interests: Novartis, Roche
Honoraria: Amgen, Novartis, Bristol Myers Squibb/Celgene
Consulting or Advisory Role: Bristol Myers Squibb/Celgene
No other potential conflicts of interest were reported.
留言 (0)